Cell Culture Media Market
Number of pages: 100 | Report Format: PDF | Published date: June 08, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 5.45 billion |
|
Revenue Forecast in 2031 |
US$ 14.17 billion |
|
CAGR |
11.20% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Consumables, Products, Applications, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global cell culture market was valued at US$ 5.45 billion in 2022 and is expected to register a revenue CAGR of 11.20% to reach US$ 14.17 billion by 2031.
Cell Culture Media Market Fundamentals
Cell culture media are intricate mixtures of nutrients, growth factors, salts, and other substances that are designed to create the ideal environment for the in vitro development and maintenance of cells. Cell research, drug development, and biotechnology are just a few of the uses for these media. A variety of inorganic salts, including sodium, potassium, calcium, and magnesium salts, are commonly included in cell culture medium. These salts support osmotic equilibrium and supply necessary ions for cell development. Amino acids are essential for protein synthesis and cell development since they are the building blocks of proteins. A combination of essential and non-essential amino acids is frequently used in cell culture medium to assist protein synthesis and cellular metabolism.
Cell culture media are primarily used to promote the in vitro growth and maintenance of cells. It is possible to examine cells' behavior, cellular processes, and stimuli-response characteristics by cultivating them in the proper medium from various tissues and species. Researchers may study cell biology, genetics, molecular biology, and many physiological and pathological processes with this program, which is frequently utilized in fundamental research. Drug research and development procedures heavily rely on cell culture medium. The effectiveness, toxicity, and safety of prospective drug candidates can be screened and assessed using cells cultivated in certain mediums. These cellular models shed light on the interactions between medications and cells, drug metabolism, and the impact of pharmaceuticals on cellular processes. To evaluate the activity and selectivity of drugs, high-throughput screening systems frequently use cell culture medium.
Cell Culture Media Market Dynamics
The industry's growth is predicted to be boosted by improvements in 3D culture technologies and their rising use for biopharmaceutical manufacturing, drug discovery, and tissue engineering applications. Cell culture techniques are now being used more often in research and development since recent advances in gene expression technologies have made it possible to produce innovative vaccines and biopharmaceuticals. Additionally, it is anticipated that the market will be driven by an increase in the number of cancer research initiatives and a wider range of gene therapy applications.
Due to the high cost and specialized knowledge needed to build up cell culture infrastructure, the need for cytological services offered by contract research firms is anticipated to increase. Additionally, because of the significant sums of money invested in this field in recent years, research into regenerative treatment has experienced great progress. The market is anticipated to see rapid expansion in the near future since cell culture techniques are a crucial stage in these research applications.
The major market participants are making efforts to diversify their product offerings and improve their market positioning. For instance, in January 2022, Nucleus Biologics and Cytiva (Danaher Corporation) worked together to produce a specialized culture medium for cell and gene treatments. In order to increase their market position, new firms are also expanding their current service offerings. For instance, KromaTiD increased its services in February 2022 by including cell and blood culture isolation, processing, and quality control services.
According to GLOBOCAN Statistics, there were reportedly 19.3 million new cancer cases worldwide in 2020, and 30.2 million cases are anticipated by 2040. Since there is a growing need for precision medicine due to the burden of cancer, it is anticipated that demand for cell culture will rise in the upcoming years since cell culture is essential to the creation of customized treatment. The market is also expected to rise significantly as a result of increased pharmaceutical and biopharmaceutical research & development. For instance, the European pharmaceutical sector spent EUR 39,656 million on research and development in 2017, and EUR 41,500 million is anticipated to be spent in 2022, according to the European Federation of Pharmaceutical Industries and Associations 2022 study. The market is growing as a result of the increased emphasis on research & development, which necessitates the use of cell cultures to assess the efficacy of the treatment.
Cell Culture Media Market Ecosystem
The global cell culture media market is analyzed from the following perspectives by consumables, products, applications, and region.
Cell Culture Media Market by Consumables
Based on the consumables, the global cell culture media market is segmented into media, sera, and reagents.
The increased demand for the media segment for research and development applications resulted in media holding the greatest revenue share of over 50% in 2022. The market penetration for media has expanded because of the availability of a number of tailored, serum- and animal-component-free alternatives. In addition, the commercialization of specialized media for stem cell applications is likely to accelerate the segment's growth. Companies like Sartorius AG and Thermo Fisher Scientific, Inc., for instance, provide media products that are designed for stem cell cultivation.
Cell Culture Media Market by Products
Based on the products, the global cell culture media market is segmented into culture systems, incubators, centrifuges, cryostorage equipment, biosafety equipment, and pipetting instruments.
In 2022, culture systems held a dominating 20.0% share of the market. As a result of the advancement of technologically sophisticated and automated culturing techniques, the category is also anticipated to record the fastest CAGR throughout the projected period. For example, CELLINK will introduce its BIO CELLX bio-dispensing platform in March 2022 to automate 3D cell-based tests for drug development and cancer research. Such product introductions are anticipated to increase the segment's growth possibilities.
Benchtop centrifuges are becoming more productive and reliable for routine laboratory usage; hence centrifuges are expected to experience a considerable increase throughout the projection period. Furthermore, high-quality, rapid, and high-yield cell separation using bioprocessing centrifuges is commercially accessible, which may help the approach become more widely used. The market for the product is anticipated to increase in the near future because of the increasing need for centrifuges for the manufacturing of gene therapies, antibodies, and vaccines.
Cell Culture Media Market by Application
Based on the application, the global cell culture media market is segmented into biopharmaceuticals, tissue culture & engineering, vaccine production, drug development, gene therapy, toxicity testing, cancer research, and others.
The biopharmaceuticals segment holds the highest revenue share of almost 20.2% in 2022. The use of cell culture techniques in the production of biopharmaceuticals is predicted to increase since mammalian cell lines, including the Chinese hamster ovary, are used in the process as well as the growing desire for non-conventional medicines. The growth prospects in the biopharmaceutical industry have also increased as a result of the recent introduction of a number of grafting methods and tailored treatment alternatives.
Over the forecast period, the drug development segment is anticipated to grow rapidly. The discovery of new drugs and medical research both depend on cell culture. Target identification, lead finding and optimization, preclinical validation, clinical trials, and approval for clinical usage are all steps in the lengthy and expensive process of drug development. Currently, tissue culture-optimized plastic surfaces are being used for cell-based high throughput screening (HTS) on cultured cells grown in two dimensions (2D). The development of 3D cell culture has made the HTS procedure simpler and more precise.
Additionally, the market expansion is being aided by the funding given to medication research by various national governments. For instance, the Union Government of India introduced the "Nishank" Drug Discovery Hackathon in July 2020. A number of departments and industry participants are sponsoring this Hackathon, a first-of-its-kind national initiative to aid in the drug development process.
Cell Culture Media Market by Region
Based on the region, the global cell culture media market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East.
The cell culture market is currently dominated by North America, which is anticipated to continue during the projected period. This is primarily related to the rising need for customized treatment, which is also being accompanied by an increase in the demand for vaccines, biopharmaceuticals, and artificial organs, as well as the existence of significant market participants. In the United States, there will be an expected 1,918,030 new cancer cases in 2022, according to estimates provided by the American Cancer Society. Precision medicine is required due to the rising prevalence of illnesses like cancer, increasing the need for cell culture supplies and consumables, fueling the market's expansion.
The introduction of new goods by industry participants is also anticipated to fuel market expansion. For instance, eNuvio Canada introduced the EB-Plate, one of the first fully reusable 3D cell culture microplates, in December 2020. Such releases are anticipated to accelerate the market's expansion in the area. Additionally, in February 2022, KromaTiD introduced a full range of services for the growth, isolation, processing, and quality assurance of cell and blood cultures. The firms' introduction of such goods and services also increases consumer demand for cell culture supplies, which is anticipated to fuel the market's expansion.
Cell Culture Media Competitive Landscape
Some of the prominent market players in the global cell culture market include,
Cell Culture Media Strategic Development
Cell culture media are intricate mixtures of nutrients, growth factors, salts, and other substances that are created to create the ideal environment for the in vitro development and maintenance of cells.
The media segment led the global cell culture market.
North American region is dominating the global cell culture market.
The rising use of biopharmaceutical manufacturing in drug discovery and the number of cancer research initiatives are the prime driving factors.
The revenue CAGR of the cell culture market during the forecast period will be 11.20%.
*Insights on financial performance are subject to the availability of information in the public domain